NYSE:NGVT - Ingevity Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Ingevity Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $89.70 +0.99 (+1.12 %) (As of 12/9/2019 01:56 PM ET) Add Compare Today's Range$88.44Now: $89.70▼$89.8050-Day Range$83.14MA: $88.76▼$93.8352-Week Range$72.59Now: $89.70▼$120.41Volume1,358 shsAverage Volume193,359 shsMarket Capitalization$3.75 billionP/E Ratio21.72Dividend YieldN/ABeta2.08 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CUSIPN/A CIK1653477 Webhttp://www.ingevity.com/ Phone843-740-2300Debt Debt-to-Equity Ratio3.01 Current Ratio2.39 Quick Ratio1.38Price-To-Earnings Trailing P/E Ratio21.72 Forward P/E Ratio18.73 P/E Growth1.85 Sales & Book Value Annual Sales$1.13 billion Price / Sales3.31 Cash Flow$5.62 per share Price / Cash Flow15.97 Book Value$8.07 per share Price / Book11.12Profitability EPS (Most Recent Fiscal Year)$4.13 Net Income$169.10 million Net Margins14.31% Return on Equity53.69% Return on Assets10.79%Miscellaneous Employees1,750 Outstanding Shares41,820,000Market Cap$3.75 billion Next Earnings Date2/12/2020 (Estimated) OptionableOptionable Receive NGVT News and Ratings via Email Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter. NGVT Rates by TradingView Ingevity (NYSE:NGVT) Frequently Asked Questions What is Ingevity's stock symbol? Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT." How were Ingevity's earnings last quarter? Ingevity Corp (NYSE:NGVT) issued its earnings results on Wednesday, October, 23rd. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.42 by $0.04. The firm had revenue of $359.90 million for the quarter, compared to analysts' expectations of $365.44 million. Ingevity had a net margin of 14.31% and a return on equity of 53.69%. Ingevity's revenue was up 15.6% on a year-over-year basis. During the same quarter last year, the company posted $1.16 earnings per share. View Ingevity's Earnings History. When is Ingevity's next earnings date? Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Ingevity. What guidance has Ingevity issued on next quarter's earnings? Ingevity issued an update on its FY 2019 earnings guidance on Wednesday, October, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.28-1.3 billion, compared to the consensus revenue estimate of $1.33 billion. What price target have analysts set for NGVT? 8 Wall Street analysts have issued 1-year target prices for Ingevity's stock. Their forecasts range from $96.00 to $130.00. On average, they anticipate Ingevity's stock price to reach $110.38 in the next twelve months. This suggests a possible upside of 23.0% from the stock's current price. View Analyst Price Targets for Ingevity. What is the consensus analysts' recommendation for Ingevity? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity. Has Ingevity been receiving favorable news coverage? News coverage about NGVT stock has been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ingevity earned a news impact score of -1.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Ingevity. Are investors shorting Ingevity? Ingevity saw a decline in short interest during the month of November. As of November 15th, there was short interest totalling 982,000 shares, a decline of 8.2% from the October 31st total of 1,070,000 shares. Based on an average daily volume of 310,700 shares, the short-interest ratio is currently 3.2 days. Currently, 2.4% of the company's shares are sold short. View Ingevity's Current Options Chain. Who are some of Ingevity's key competitors? Some companies that are related to Ingevity include FMC (FMC), Johnson Matthey (JMPLY), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), KURARAY CO LTD/ADR (KURRY), Univar (UNVR), Balchem (BCPC), Olin (OLN), Chemours (CC), Innospec (IOSP), PQ Group (PQG), GCP Applied Technologies (GCP), Livent (LTHM) and Innophos (IPHS). What other stocks do shareholders of Ingevity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Costco Wholesale (COST), NVIDIA (NVDA), General Electric (GE), Quaker Chemical (KWR), Paypal (PYPL), Zebra Technologies (ZBRA), AbbVie (ABBV), Boeing (BA), Pfizer (PFE) and UnitedHealth Group (UNH). Who are Ingevity's key executives? Ingevity's management team includes the folowing people: Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58) Who are Ingevity's major shareholders? Ingevity's stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (3.17%), Massachusetts Financial Services Co. MA (2.43%), Chilton Investment Co. LLC (1.56%), Rice Hall James & Associates LLC (1.17%), Ardevora Asset Management LLP (0.75%) and Copper Rock Capital Partners LLC (0.59%). Company insiders that own Ingevity stock include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Institutional Ownership Trends for Ingevity. Which major investors are selling Ingevity stock? NGVT stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Chilton Investment Co. LLC, Millennium Management LLC, Calamos Advisors LLC, Copper Rock Capital Partners LLC, Pictet Asset Management Ltd., Chartwell Investment Partners LLC and Kornitzer Capital Management Inc. KS. Company insiders that have sold Ingevity company stock in the last year include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Insider Buying and Selling for Ingevity. Which major investors are buying Ingevity stock? NGVT stock was bought by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Stifel Financial Corp, Massachusetts Financial Services Co. MA, Rice Hall James & Associates LLC, Tygh Capital Management Inc., Squarepoint Ops LLC, Russell Investments Group Ltd. and Eagle Asset Management Inc.. View Insider Buying and Selling for Ingevity. How do I buy shares of Ingevity? Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Ingevity's stock price today? One share of NGVT stock can currently be purchased for approximately $89.70. How big of a company is Ingevity? Ingevity has a market capitalization of $3.75 billion and generates $1.13 billion in revenue each year. The company earns $169.10 million in net income (profit) each year or $4.13 on an earnings per share basis. Ingevity employs 1,750 workers across the globe.View Additional Information About Ingevity. What is Ingevity's official website? The official website for Ingevity is http://www.ingevity.com/. How can I contact Ingevity? Ingevity's mailing address is 5255 Virginia Avenue, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected] MarketBeat Community Rating for Ingevity (NYSE NGVT)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 313 (Vote Outperform)Underperform Votes: 294 (Vote Underperform)Total Votes: 607MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2019 by MarketBeat.com StaffFeatured Article: Inverted Yield Curve